Shu (Melinda) Chen is a third-year Ph.D. candidate, CEPAR and School of Risk and Actuarial Sciences, UNSW (Scientia Scholarships holder), and a senior consultant for the Duke Global Health Institute. She has around a decade of working experience in health policy and system research, and worked closely with international global health funders and partners, such as the Gates Foundation, World Bank, and NIH. She has published over 20 co-authored publications in high-quality peer-reviewed medical journals such as The Lancet Public Health, PLOS Medicine, and BMJ Global Health. She was Associate Director of Research for Infectious Diseases Portfolio, China, FHI 360 and worked at the Global Health Research Center, Duke Kunshan University on health policy and system research before joining UNSW.